Press Releases
GT Biopharma to Present New Data on Novel Dual-Antigen Targeting Approach Against AML at Upcoming 2022 ASH Annual Meeting
GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update
GT Biopharma Presents at LD Micro on October 26, 2022 at 4:30 pm PST
GT Biopharma Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
GT Biopharma Announces Adjournment of Special Shareholders Meeting
GT Biopharma Poster Presentation and Mini Oral Session at ESMO Congress 2022 Demonstrates GTB-5550 TriKE® Ability to Specifically Target and Efficiently Kill Multiple B7H3+ Solid and Hematologic Malignancies
GT Biopharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference in September
GT Biopharma Affirms Manufacturing Timeline For Lead Investigational Asset GTB-3650
GT Biopharma Reports Second Quarter Fiscal 2022 Financial Results and Business Update
